BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23815043)

  • 1. Are independent pharmacies in need of special care? An argument against an antitrust exemption for collective negotiations of pharmacists.
    Rosenthal DB
    Yale J Health Policy Law Ethics; 2013; 13(1):198-252. PubMed ID: 23815043
    [No Abstract]   [Full Text] [Related]  

  • 2. Conscience in context: pharmacist rights and the eroding moral marketplace.
    Vischer RK
    Stanford Law Pol Rev; 2006; 17(1):83-119. PubMed ID: 17165232
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug maker's efforts to compete in lucrative insulin market are under scrutiny.
    Harris G; Pear R
    N Y Times Web; 2006 Jan; ():A14. PubMed ID: 16453399
    [No Abstract]   [Full Text] [Related]  

  • 4. Physician negotiations with managed care plans: an antitrust primer.
    Ronai SE; Hudner HK
    Med Staff Couns; 1993; 7(3):57-66. PubMed ID: 10126801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finance issue brief: any willing provider: year end report-2002.
    Morgan R; MacEachern L
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-10. PubMed ID: 12884878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency contraception, institutional conscience, and pharmacy practice.
    Card RF; Williams KG
    J Pharm Pract; 2014 Apr; 27(2):174-7. PubMed ID: 24352808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacies take uniform price demands to court.
    Moskowitz DB
    J Am Health Policy; 1994; 4(4):24-7. PubMed ID: 10136676
    [No Abstract]   [Full Text] [Related]  

  • 8. Seducing the medical profession.
    N Y Times Web; 2006 Feb; ():A22. PubMed ID: 16502529
    [No Abstract]   [Full Text] [Related]  

  • 9. Texas' new physician collective bargaining statute: helping to fatten physicians' wallets and make patients' leaner.
    Mayo TW; King JP
    Health Care Law Mon; 1999 Sep; ():3-13. PubMed ID: 10623065
    [No Abstract]   [Full Text] [Related]  

  • 10. [Apothecaries and pharmacies in the Radziwill family estates in the 18th century].
    Zuba K
    Kwart Hist Kult Mater; 2001; 49(4):345-66. PubMed ID: 18705164
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacy practice developments: the potential impact on pharmacists' legal liability.
    Hattingh L; Forrester K; Smith N; Searle J
    J Law Med; 2007 Feb; 14(3):397-402. PubMed ID: 17355101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illinois pharmacies ordered to provide birth control.
    Davey M
    N Y Times Web; 2005 Apr; ():A10. PubMed ID: 15940858
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitrust, health care quality, and the courts.
    Hammer PJ; Sage WM
    Columbia Law Rev; 2002 Apr; 102(3):545-649. PubMed ID: 11985363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical pricing. Let the market decide who gets discounts.
    Mossinghoff GJ
    Health Syst Rev; 1995; 28(1):24-5. PubMed ID: 10139754
    [No Abstract]   [Full Text] [Related]  

  • 15. Revised antitrust guidelines. Forming physician network joint ventures.
    Anderson KR
    Physician Exec; 1997 Feb; 23(2):24-6. PubMed ID: 10164971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intersection of quality metrics and Medicare policy.
    Nau DP
    Ann Pharmacother; 2011 Dec; 45(12):1582-4. PubMed ID: 22045907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conflict of interest: why peer review committees need heightened scrutiny under federal antitrust law.
    Rakestraw E
    J Leg Med; 2009; 30(4):563-78. PubMed ID: 19953408
    [No Abstract]   [Full Text] [Related]  

  • 18. The Feds ease antitrust rules--cautiously.
    Guglielmo WJ
    Med Econ; 2002 Jun; 79(12):55-6. PubMed ID: 12119738
    [No Abstract]   [Full Text] [Related]  

  • 19. The regulation of pharmacy ownership in Australia: the potential impact of changes to the health landscape.
    Hattingh HL
    J Law Med; 2011 Sep; 19(1):147-54. PubMed ID: 21988016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA inspections of pharmacies: what should you do?
    Gibbs JN
    Am Pharm; 1995 May; NS35(5):32-3, 35. PubMed ID: 7611135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.